While these therapies yield impressive results in melanoma and lung cancer, only about 10% of patients with HNSCC experience durable responses. Tongue squamous cell carcinoma (TSCC), the most ...

While these therapies yield impressive results in melanoma and lung cancer, only about 10% of patients with HNSCC experience durable responses. Tongue squamous cell carcinoma (TSCC), the most ...

ICB therapies work by blocking immune checkpoint molecules that normally suppress immune cell activity, allowing T cells to attack tumors more effectively. The results were striking: the ...

Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei 11529, Taiwan Graduate Institute of Nanomedicine and Medical ...